The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
Molecular screening: Multinational testing doable, but technical challenges remain A pilot study demonstrated that a large-scale, international screening programme for women with metastatic breast cancer is feasible. The study, coordinated by the Institut Jules Bordet and the Breast International Gr...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f8462052d39a42d18d1d361021e2031f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f8462052d39a42d18d1d361021e2031f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f8462052d39a42d18d1d361021e2031f2021-12-02T12:30:31ZThe AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group10.1038/s41523-017-0026-62374-4677https://doaj.org/article/f8462052d39a42d18d1d361021e2031f2017-06-01T00:00:00Zhttps://doi.org/10.1038/s41523-017-0026-6https://doaj.org/toc/2374-4677Molecular screening: Multinational testing doable, but technical challenges remain A pilot study demonstrated that a large-scale, international screening programme for women with metastatic breast cancer is feasible. The study, coordinated by the Institut Jules Bordet and the Breast International Group, aimed to determine whether biopsies and blood could be collected from women with metastatic breast cancer across Europe and sent to a central laboratory for targeted gene sequencing. Genetic information was successfully obtained for 26 of the 41 participants, 19 of whom had mutations that could be targeted with a known drug, potentially influencing treatment decision-making. They concluded that genomic testing is logistically ready for international molecular screening in routine clinical settings laying the groundwork for the parent European AURORA molecular screening programme which aims at recruiting 1300 metastatic breast cancer patients. However, technical challenges remain to be addressed to ensure the accuracy and robustness across different sequencing platforms.Marion MaetensDavid BrownAlexandre IrrthumPhilippe AftimosGiuseppe VialeSibylle LoiblJean-François LaesPeter J. CampbellAlastair ThompsonJavier CortesSabine SeilerSara VinnicombeMafalda OliveiraFrançoise RothéYacine BarecheDebora FumagalliDimitrios ZardavasChristine DesmedtMartine PiccartSherene LoiChristos SotiriouNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Breast Cancer, Vol 3, Iss 1, Pp 1-10 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Marion Maetens David Brown Alexandre Irrthum Philippe Aftimos Giuseppe Viale Sibylle Loibl Jean-François Laes Peter J. Campbell Alastair Thompson Javier Cortes Sabine Seiler Sara Vinnicombe Mafalda Oliveira Françoise Rothé Yacine Bareche Debora Fumagalli Dimitrios Zardavas Christine Desmedt Martine Piccart Sherene Loi Christos Sotiriou The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group |
description |
Molecular screening: Multinational testing doable, but technical challenges remain A pilot study demonstrated that a large-scale, international screening programme for women with metastatic breast cancer is feasible. The study, coordinated by the Institut Jules Bordet and the Breast International Group, aimed to determine whether biopsies and blood could be collected from women with metastatic breast cancer across Europe and sent to a central laboratory for targeted gene sequencing. Genetic information was successfully obtained for 26 of the 41 participants, 19 of whom had mutations that could be targeted with a known drug, potentially influencing treatment decision-making. They concluded that genomic testing is logistically ready for international molecular screening in routine clinical settings laying the groundwork for the parent European AURORA molecular screening programme which aims at recruiting 1300 metastatic breast cancer patients. However, technical challenges remain to be addressed to ensure the accuracy and robustness across different sequencing platforms. |
format |
article |
author |
Marion Maetens David Brown Alexandre Irrthum Philippe Aftimos Giuseppe Viale Sibylle Loibl Jean-François Laes Peter J. Campbell Alastair Thompson Javier Cortes Sabine Seiler Sara Vinnicombe Mafalda Oliveira Françoise Rothé Yacine Bareche Debora Fumagalli Dimitrios Zardavas Christine Desmedt Martine Piccart Sherene Loi Christos Sotiriou |
author_facet |
Marion Maetens David Brown Alexandre Irrthum Philippe Aftimos Giuseppe Viale Sibylle Loibl Jean-François Laes Peter J. Campbell Alastair Thompson Javier Cortes Sabine Seiler Sara Vinnicombe Mafalda Oliveira Françoise Rothé Yacine Bareche Debora Fumagalli Dimitrios Zardavas Christine Desmedt Martine Piccart Sherene Loi Christos Sotiriou |
author_sort |
Marion Maetens |
title |
The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group |
title_short |
The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group |
title_full |
The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group |
title_fullStr |
The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group |
title_full_unstemmed |
The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group |
title_sort |
aurora pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/f8462052d39a42d18d1d361021e2031f |
work_keys_str_mv |
AT marionmaetens theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT davidbrown theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT alexandreirrthum theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT philippeaftimos theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT giuseppeviale theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT sibylleloibl theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT jeanfrancoislaes theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT peterjcampbell theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT alastairthompson theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT javiercortes theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT sabineseiler theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT saravinnicombe theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT mafaldaoliveira theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT francoiserothe theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT yacinebareche theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT deborafumagalli theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT dimitrioszardavas theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT christinedesmedt theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT martinepiccart theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT shereneloi theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT christossotiriou theaurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT marionmaetens aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT davidbrown aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT alexandreirrthum aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT philippeaftimos aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT giuseppeviale aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT sibylleloibl aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT jeanfrancoislaes aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT peterjcampbell aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT alastairthompson aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT javiercortes aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT sabineseiler aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT saravinnicombe aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT mafaldaoliveira aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT francoiserothe aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT yacinebareche aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT deborafumagalli aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT dimitrioszardavas aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT christinedesmedt aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT martinepiccart aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT shereneloi aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup AT christossotiriou aurorapilotstudyformolecularscreeningofpatientswithadvancedbreastcancerastudyofthebreastinternationalgroup |
_version_ |
1718394373445517312 |